Volume | 152,597 |
|
|||||
News | - | ||||||
Day High | 20.77 | Low High |
|||||
Day Low | 20.40 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Fulgent Genetics Inc | FLGT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
20.51 | 20.40 | 20.77 | 20.74 | 20.64 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
3,854 | 152,597 | $ 20.60 | $ 3,143,310 | - | 19.88 - 44.09 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:01:32 | 20 | $ 21.21 | USD |
Fulgent Genetics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
618.03M | 29.78M | - | 289.21M | -167.83M | -5.63 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Fulgent Genetics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FLGT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 20.81 | 21.05 | 19.88 | 20.31 | 180,019 | -0.22 | -1.06% |
1 Month | 21.71 | 22.16 | 19.88 | 20.97 | 161,742 | -1.12 | -5.16% |
3 Months | 24.95 | 26.365 | 19.88 | 23.05 | 222,552 | -4.36 | -17.47% |
6 Months | 25.42 | 30.68 | 19.88 | 25.06 | 210,361 | -4.83 | -19.00% |
1 Year | 29.97 | 44.09 | 19.88 | 29.54 | 216,680 | -9.38 | -31.30% |
3 Years | 84.71 | 112.00 | 19.88 | 60.47 | 362,116 | -64.12 | -75.69% |
5 Years | 7.49 | 189.8899 | 4.712 | 59.70 | 509,367 | 13.10 | 174.90% |
Fulgent Genetics Description
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign. |